Back to search

Article

An integral genomic signature approach for tailored cancer targeted therapy using genome-wide sequencing data

2021-02-18

Abstract excerpt

<h4>ABSTRACT</h4> With the advent of low-cost sequencing, transcriptome and genome sequencing is expected to become clinical routine and transform precision oncology within next decade. However, viable genome-wide modeling methods that can facilitate rational selection of patients for tailored intervention while tolerating sequencing biases are far lacking. Here we propose an integral genomic signature (iGenSig)...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a17f5fd-2d09-5244-aa10-cfa7c1140403
DOI
10.1101/2021.02.17.431663
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
An integral genomic signature approach for tailored cancer targeted therapy using genome-wide sequencing dataDOI 10.1101/2021.02.17.431663
Select a neighboring publication to make it the new centre.